Hjem › Myelofibrose › Illinois › Chicago
Kliniske studier for Myelofibrose i Chicago, IL
7 studier for Myelofibrose søker deltakere på steder i og rundt Chicago (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
RekruttererFase 1/2
- University of Chicago, Chicago
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RekruttererFase 2
- University of Chicago Comprehensive Cancer Center, Chicago
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
RekruttererFase 1
- University of Chicago Medical Center, Chicago
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RekruttererFase 1
- University of Chicago, Chicago
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
RekruttererObservasjonsstudie
- MPN Research Foundation, Chicago
Selumetinib and Azacitidine in High Risk Chronic Blood Cancers
RekruttererFase 1
- The University of Chicago, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Chicago
Myelofibrose-studier i andre byer
- Houston, TX19 studier
- New York City, NY18 studier
- Boston, MA12 studier
- Durham, NC12 studier
- Columbus, OH11 studier
- Seattle, WA11 studier
- Salt Lake City, UT10 studier
- Miami, FL10 studier
- Nashville, TN9 studier
- Cleveland, OH9 studier
- Tampa, FL9 studier
- Atlanta, GA9 studier
Andre studier i Chicago
- Ikke-småcellet lungekreft61 studier
- Brystkreft58 studier
- Kreft (alle typer)51 studier
- Metastatisk kreft45 studier
- Prostatakreft45 studier
- Fedme41 studier
- Lungekreft41 studier
- Eggstokkreft36 studier
- Slag34 studier
- Kolorektal kreft33 studier
- Hjertesvikt31 studier
- Overvekt28 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.